Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Walgreen Co To Acquire BioScrip Inc's Community Specialty Pharmacies And Centralized Specialty And Mail Service Pharmacy Businesses
Walgreen Co and BioScrip Inc announced that they have entered into a definitive agreement under which Walgreens would acquire certain assets of BioScrip's community specialty pharmacies and centralized specialty and mail service pharmacy businesses and BioScrip would receive a total deal value of approximately $225 million. This includes approximately $170 million in cash at closing and retention by BioScrip of associated accounts receivable and working capital liabilities of approximately $55 million. Up to an additional $60 million in purchase price may be payable based on events related directly or indirectly to Walgreens retention of certain business included in the transferred businesses.
Latest Key Developments in Healthcare
- NICHII GAKKAN CO Amends Consolidated Mid-year Outlook for FY 2014
- Cryo Save Group NV Appoints Walter van Pottelberge As Chairman To Replace Johan Goossens-DJ
- Feelgood Svenska publ AB to Acquire Hagabadet Holding AB
- Primary Health Properties PLC Announces Proposed Firm Placing And Placing, Open Offer
- Share this
- Link this
- Digg this


Follow Reuters